or Try an Advanced Search...

    Cardiovascular Products Stocks List

    Symbol Grade Name % Change
    OPK D OPKO Health Inc. 2.01
    LLY D Eli Lilly and Company 0.75
    ATRI B ATRION Corporation 0.00
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Vascular Products Alzheimer's Disease Antibiotics Ophthalmic Pharmaceutical Products Active Pharmaceutical Ingredients Amyloid Anesthesia Animal Health Animal Health Products Asthma Attention Deficit Hyperactivity Disorder Autoimmune Disease Bacterial Infections Balloon Catheter Benign Prostatic Hyperplasia Biomarkers Bipolar Depression Bipolar Disorder Bypass

    Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Products stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 21.61
    OZEM D Roundhill GLP-1 & Weight Loss ETF 19.98
    MEDX D Horizon Kinetics Medical ETF 16.63
    THNR D Amplify Weight Loss Drug & Treatment ETF 14.78
    PPH D Market Vectors Pharmaceutical ETF 12.88
    View all Cardiovascular Products ETFs...
    Compare ETFs
    Compare IHE to MEDX Compare OZEM to MEDX Compare OZEM to PPH

        Cardiovascular Products Stocks Recent News

        Date Stock Title
        Oct 2 LLY Jim Cramer Remains Steadfast On Eli Lilly and Company (NYSE:LLY)
        Oct 2 LLY Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
        Oct 2 OPK Here's Why You Should Retain OPKO Health Stock in Your Portfolio
        Oct 2 LLY Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
        Oct 2 LLY Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
        Oct 2 LLY Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
        Oct 2 LLY Eli Lilly Building $4.5B Pharmaceutical Factory in Indiana
        Oct 2 LLY Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
        Oct 2 LLY Eli Lilly Plans $4.5 Billion Research Hub
        Oct 2 LLY Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
        Oct 2 LLY Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
        Oct 2 LLY Eli Lilly is building a $4.5 billion factory to speed up drug production
        Oct 2 LLY Eli Lilly announces $4.5B production/R&D site in Indiana
        Oct 2 LLY Lilly to invest $4.5B on new Indiana facility
        Oct 2 LLY Lilly to invest $4.5 billion on new Indiana facility
        Oct 2 LLY Lilly announces new $4.5 billion site - the Lilly Medicine Foundry - to drive innovation in drug production and make medicines for clinical trials
        Oct 2 LLY Lilly plans $4.5B ‘foundry’ for advanced drug manufacturing
        Oct 2 LLY Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
        Oct 1 LLY U.S. port strike expected to have limited impact on healthcare supply chain: HHS
        Oct 1 LLY Here's how AI is set to disrupt healthcare — albeit slowly
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Vascular Products Alzheimer's Disease Antibiotics Ophthalmic Pharmaceutical Products Active Pharmaceutical Ingredients Amyloid Anesthesia Animal Health Animal Health Products Asthma Attention Deficit Hyperactivity Disorder Autoimmune Disease Bacterial Infections Balloon Catheter Benign Prostatic Hyperplasia Biomarkers Bipolar Depression Bipolar Disorder Bypass
        Cardiovascular Products

        Cardiovascular products are medical devices and pharmaceuticals used to treat and diagnose cardiovascular diseases. These products include pacemakers, stents, catheters, heart valves, and drugs used to treat heart conditions. Cardiovascular products are used to improve the quality of life for patients with heart conditions and to reduce the risk of death from cardiovascular diseases.

        Browse All Tags